Clinical Study

China Adrenal Disease Registry (CASE)

Summary

In order to meet all the challenges in the diagnosis and treatment of adrenal diseases in China, CASE was founded in 2020. With advanced medical equipment and Internet of Things (IoT) technology, CASE is committed to creating an online and offline integrated solution for adrenal disease, and for the entire spectrum of adrenal disease, to achieve a more convenient and precise model of care for patients, aiming to establish a platform with diagnosis and treatment of adrenal disease and their long-term follow-up. It allows the application and evaluation of treatment strategies at these centers.

Study Name: China Adrenal Disease Registry Study (CASE)

Status: Recruiting

Conditions: Cushing Syndrome, Aldosteronism, Hypoadrenalism, Congenital Adrenal Hyperplasia, Adrenal Adenoma, Adrenal Incidentaloma, Adrenal Carcinoma, Pheochromocytoma,, Primary aldosteronism

Interventions: Observational Only

Locations: Shanghai Jiao Tong University School of Medicine, Shanghai, China

Study link: https://clinicaltrials.gov/ct2/show/NCT04890444

To search for other studies by topic, location, or status, go to our Clinical Studies page.